Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.190
+0.070 (1.70%)
At close: May 29, 2026, 4:00 PM EDT
4.323
+0.133 (3.17%)
After-hours: May 29, 2026, 5:43 PM EDT
Cytek Biosciences Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Cytek Biosciences stock has a consensus rating of "Buy" and an average price target of $5.69. The average 1-year stock price forecast is 35.80% higher than the current stock price, while the lowest is $4.75 (+13.37%) and the highest is $7.50 (+79.00%).
Price Target: $5.69 (+35.80%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Cytek Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens | Stephens | Buy Reiterates $4.75 | Buy | Reiterates | $4.75 | +13.37% | May 13, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $5.5 → $4.12 | Hold | Reiterates | $5.5 → $4.12 | -1.67% | May 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $7.5 | Buy | Maintains | $7.5 | +79.00% | May 8, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $5 | Hold | Maintains | $5 | +19.33% | May 8, 2026 |
Financial Forecast
Revenue This Year
212.94M
from 201.49M
Increased by 5.68%
Revenue Next Year
227.05M
from 212.94M
Increased by 6.63%
EPS This Year
-0.36
from -0.52
EPS Next Year
-0.25
from -0.36
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 220.2M | 236.8M | |
| Avg | 212.9M | 227.1M | |
| Low | 203.6M | 211.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.3% | 11.2% | |
| Avg | 5.7% | 6.6% | |
| Low | 1.1% | -0.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.30 | -0.23 | |
| Avg | -0.36 | -0.25 | |
| Low | -0.40 | -0.26 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.